Genmab A/s Share Price (NASDAQ: GMAB)
$24.88
Last updated on
Check the interactive Genmab A/s Stock chart to analyse performance
Genmab A/s stock performance
as on August 30, 2025 at 1:29 am IST
- Today's Low:$24.78Today's High:$24.97
0.42%
Downside
Day's Volatility :0.78%
Upside
0.36%
- 52 Weeks Low:$17.2452 Weeks High:$27.91
30.73%
Downside
52 Weeks Volatility :38.25%
Upside
10.86%
Genmab A/s Stock Returns
Genmab A/s Key Stats
Check Genmab A/s key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.
Stock Returns calculator for Genmab A/s Stock including INR - Dollar returns
The Genmab A/s stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Genmab A/s investment value today
Current value as on today
₹96,054
Returns
Returns from Genmab A/s Stock
Dollar Returns*
₹5,284 (+5.28%)
Indian investors sentiment towards Genmab A/s Stock
Global Institutional Holdings in Genmab A/s
Name
Holdings %
AllianceBernstein L.P.
2.39%
Orbis Allan Gray Ltd
1.29%
Citadel Advisors Llc
0.72%
BlackRock Inc
0.57%
Harding Loevner L.P.
0.48%
Morgan Stanley - Brokerage Accounts
0.46%
Analyst Recommendation on Genmab A/s Stock
Buy
61%Buy
29%Hold
9%Sell
Based on 31 Wall street analysts offering stock ratings for Genmab A/s(by analysts ranked 0 to 5 stars)
- Current
- 1M Ago
- 3M Ago
Genmab A/s Share Price Target
What analysts predicted
Upside of 22.84%
Target:
$30.56
Current:
$24.88
Genmab A/s share price target is $30.56, a slight Upside of 22.84% compared to current price of $24.88 as per analysts' prediction.
Genmab A/s Stock Insights
Price Movement
In the last 1 month, GMAB stock has moved up by 14.7%Decreasing Revenue
Revenue is down for the last 3 quarters, 6.44B → 925.0M (in $), with an average decrease of 52.3% per quarterIncreasing Net Profit
Netprofit is up for the last 2 quarters, 195.0M → 336.0M (in $), with an average increase of 42.0% per quarterGMAB vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 69.9% return, outperforming this stock by 80.5%GMAB vs ALNY (3 yr)
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 116.0% return, outperforming this stock by 145.9%Price to Sales
ForGMAB every $1 of sales, investors are willing to pay $4.3, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $23.5 for every $1 of sales.
Genmab A/s Financials
Genmab A/s Technicals Summary
Sell
Neutral
Buy
Genmab A/s is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.
Genmab A/s Vs Peers
| Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
|---|---|---|---|---|---|
| 14.16% | 8.3% | -9.28% | -30.27% | -33.82% |
 | 3.92% | -15.2% | -50.31% | -3.3% | -2.01% |
 | 2.49% | 24.81% | 62.78% | 79.11% | 29.69% |
 | -15.42% | -19.13% | -17.84% | 34.68% | 41.87% |
 | 11.08% | 83.28% | 75.87% | 111.28% | 242.25% |
| Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
|---|---|---|---|---|---|---|---|---|
| 13.01 | 13.01 | 2.35 | 1.73 | 0.28 | 0.13 | NA | 86.21 |
| 14.6 | 14.6 | 1.2 | 39.42 | 0.15 | 0.07 | 0.0 | 287.55 |
| NA | NA | NA | 2.73 | -0.05 | -0.01 | NA | 34.32 |
| 27.86 | 27.86 | 0.58 | 18.06 | 0.23 | 0.13 | NA | 67.02 |
| NA | NA | -0.49 | 3.92 | -2.58 | -0.03 | NA | 1.91 |
| Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
|---|---|---|---|---|---|
| Buy | $15.4B | -33.82% | 13.01 | 37.59% |
| Buy | $61.4B | -2.01% | 14.6 | 31.37% |
| NA | $36.5B | 29.69% | NA | -3.89% |
| Buy | $100.5B | 41.87% | 27.86 | 31.86% |
| Buy | $59.5B | 242.25% | NA | -12.96% |
About Genmab A/s
Key Management of Genmab A/s
Important FAQs about investing in GMAB Stock from India :
What is Genmab A/s share price today?
Genmab A/s share price today is $24.88 as on at the close of the market. Genmab A/s share today touched a day high of $24.97 and a low of $24.78.
What is the 52 week high and 52 week low for Genmab A/s share?
Genmab A/s share touched a 52 week high of $27.91 and a 52 week low of $17.24. Genmab A/s stock price today i.e. is closed at $24.88, lower by 10.86% versus the 52 week high.
How to invest in Genmab A/s Stock (GMAB) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Genmab A/s on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Genmab A/s Shares that will get you 0.0603 shares as per Genmab A/s share price of $24.88 per share as on August 30, 2025 at 1:29 am IST.
What is the minimum amount required to buy Genmab A/s Stock (GMAB) from India?
Indian investors can start investing in Genmab A/s (GMAB) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Genmab A/s stock (as per the Rupee-Dollar exchange rate as on August 31, 2025).
Based on Genmab A/s share’s latest price of $24.88 as on August 30, 2025 at 1:29 am IST, you will get 0.4019 shares of Genmab A/s. Learn more about
fractional shares .
What are the returns that Genmab A/s has given to Indian investors in the last 5 years?
Genmab A/s stock has given -33.82% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?
Discover More
Mettler-toledo International Inc.$1,301.88
+1.46%
Packaging Corporation Of America$217.97
+0.61%
Axa Equitable Holdings, Inc.$53.27
+0.06%
Tjx Companies, Inc., The$136.63
-0.36%
United Therapeutics Corporation$304.74
-0.81%
Halliburton Company$22.73
+0.44%
Telus Corp$16.50
+0.36%
Vaneck Vectors Semiconductor Etf$290.23
-2.89%
Coupang, Llc$28.59
-0.14%